1. Home
  2. ALLR vs AMBO Comparison

ALLR vs AMBO Comparison

Compare ALLR & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • AMBO
  • Stock Information
  • Founded
  • ALLR 2004
  • AMBO 2000
  • Country
  • ALLR United States
  • AMBO United States
  • Employees
  • ALLR N/A
  • AMBO N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • ALLR Health Care
  • AMBO Real Estate
  • Exchange
  • ALLR Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • ALLR 4.5M
  • AMBO 5.1M
  • IPO Year
  • ALLR N/A
  • AMBO 2010
  • Fundamental
  • Price
  • ALLR $1.05
  • AMBO $1.55
  • Analyst Decision
  • ALLR
  • AMBO
  • Analyst Count
  • ALLR 0
  • AMBO 0
  • Target Price
  • ALLR N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • ALLR 218.5K
  • AMBO 157.0K
  • Earning Date
  • ALLR 11-14-2024
  • AMBO 12-27-2024
  • Dividend Yield
  • ALLR N/A
  • AMBO N/A
  • EPS Growth
  • ALLR N/A
  • AMBO N/A
  • EPS
  • ALLR N/A
  • AMBO N/A
  • Revenue
  • ALLR N/A
  • AMBO $9,163,000.00
  • Revenue This Year
  • ALLR N/A
  • AMBO N/A
  • Revenue Next Year
  • ALLR N/A
  • AMBO N/A
  • P/E Ratio
  • ALLR N/A
  • AMBO N/A
  • Revenue Growth
  • ALLR N/A
  • AMBO N/A
  • 52 Week Low
  • ALLR $0.90
  • AMBO $1.00
  • 52 Week High
  • ALLR $378.00
  • AMBO $6.30
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 39.84
  • AMBO 42.85
  • Support Level
  • ALLR $0.90
  • AMBO $1.40
  • Resistance Level
  • ALLR $1.14
  • AMBO $1.89
  • Average True Range (ATR)
  • ALLR 0.08
  • AMBO 0.18
  • MACD
  • ALLR 0.02
  • AMBO -0.04
  • Stochastic Oscillator
  • ALLR 66.67
  • AMBO 10.40

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

Share on Social Networks: